Medline homecare beds recalled Class I over hand-control fire hazard
The FDA logged the most serious recall tier on 7 October for Medline Basic and Medlite homecare beds, whose hand-control pendant and wiring can overheat and may smoke, spark, melt or catch fire.
The Food and Drug Administration has recorded a Class I recall of Medline homecare beds over a fire hazard in the hand control patients use to raise and lower them [s1]. The agency logged the enforcement report on 7 October 2026 and assigned the most serious recall classification, the tier reserved for defects that could cause serious injury or death [s1].
What the hazard is
The record describes a potential fire hazard involving the hand-control pendant and its associated wiring [s1]. The pendant or its wiring may overheat, which the FDA says can potentially lead to "smoking, sparking, melting, burning, or fire" [s1]. These are beds used in the home and in care settings by people who are often unable to move quickly or at all — the population least able to escape a fire that starts in their own bed. That is what places an electrical overheating fault in the agency's top recall tier.
What is affected
The recall covers Medline Basic Homecare Beds and Medlite Homecare Beds and their accessories, including the manual Medlite bed model MDR107000P, across all lots [s1]. It is large: the enforcement record puts the quantity at 771,127 units, distributed nationwide across the United States and its territories of Puerto Rico and Guam, and into Bermuda, Canada and Panama [s1].
The action is also an expansion. The record notes that the affected products were "added to" an earlier recall dated 26 November 2025, meaning this is a widening of a hazard already under recall rather than a wholly new discovery [s1]. Medline Industries, LP began the action itself and notified customers by letter, and the FDA records it as a voluntary, firm-initiated recall [s1]. The firm initiated it on 14 August 2026; the agency's device centre classified it on 30 September and logged the enforcement report on 7 October [s1]. Its status is ongoing [s1].
Why an expansion matters
A recall that grows is worth reading as a signal in its own right. When a manufacturer returns to an existing recall to add more products, it generally means the scope of the affected population turned out to be larger than first understood. For a device already in hundreds of thousands of homes, that widening is the practical difference between a contained problem and a broad one, which is part of why the agency's serious classification attaches to the expanded action [s1]. The record documents the hazard and the recall, not any reported fire or injury [s1].
The way the recall is being communicated also shapes how far it reaches. The FDA records that Medline notified customers by letter and that the action is voluntary and firm-initiated [s1]. A letter works well for the institutional buyers that order beds in bulk, but homecare equipment changes hands — through rentals, resale and transfers between care providers — in ways that a one-time notice to the original purchaser can miss. That gap between who was notified and who is actually using an affected bed is the recurring difficulty with home medical equipment, and it is why the record lists the recall's status as ongoing rather than closed [s1].
What to watch
Because the action is ongoing, the questions that remain are whether every affected bed is traced — difficult when units sit in private homes rather than hospitals — and what remedy the firm provides for the pendant and wiring [s1]. Anyone using one of these beds should follow the manufacturer's recall notice to check whether their model and accessories are among those listed, rather than rely on the bed's appearance.
Red flags: a hand control or its cable that feels hot, smells of burning, discolours or shows melting warrants switching the bed off and unplugging it, and contacting the manufacturer. This article describes a regulatory enforcement action and is not medical advice.
Sources
- FDA Enforcement Report Z-3228-2026: Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories — U.S. Food and Drug Administration (openFDA device/enforcement API) , October 7, 2026
Philips Lumify handheld ultrasound recalled Class I over scanning failures
The FDA logged a Class I recall of 13,206 Lumify systems on 28 October, citing software that can block scanning without network access and unstable transducer connections that may delay diagnosis or treatment.
Ventec recalls ventilators in Class I action over a connector that can reboot them
The FDA logged a Class I recall of Ventec's VOCSN, V+Pro, VC and V*Home ventilators on 28 October, citing an internal cable connector that can detach, rebooting the device and interrupting breathing support.
Class I recall hits a hospital test for a dangerous clotting reaction
The FDA logged a Class I recall of Instrumentation Laboratory's HemosIL AcuStar HIT assay on 21 October. Certain lots can read up to 47% low, risking a missed diagnosis of heparin-induced thrombocytopenia.
Penumbra recalls a stroke-clot catheter that can fracture during use
The FDA logged the recall of the RED 62 reperfusion catheter, part of the Penumbra System used to pull clots from the brain, on 7 October. Manufacturing problems mean the device may fracture; 43 units are affected.